SYMPOSIA
SYMPOSIA
SYMPOSIA
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Abstracts of the Invited Speakers<br />
[JS-02]<br />
Malaysian Psychiatric Association<br />
Symposium title: Malaysian perspective of substance dependence<br />
A harm minimization program against drug use and HIV problems in Malaysia<br />
Rusdi Abd. Rashid 1 , Abdul Kadir Bin Abu Bakar 2 , Hazli Bin Zakaria 3 , Umi Binti Adzlin 4 , Mohammad Hussain Habil 5<br />
1University of Malaya Centre for Addiction Sciences(UMCAS), Kuala Lumpur, Malaysia<br />
2Hospital Permai, Johor Bharu, Malaysia<br />
3Dept. of Psychiatry, Hospital Universiti Kebangsaan Malaysia,Kuala Lumpur, Malaysia<br />
4Dept. of Psychiatry, Kajang Hospital, Selangor, Malaysia<br />
5Dept of Psychological Medicine,Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia<br />
E-mail: rusdirashid@gmail.com<br />
This symposium highlights the drug use and HIV situations in Malaysia from the perspective of the development of a harm minimization<br />
program, methadone assisted therapy for opiate dependents, and the world’s first integrated Islamic psychospiritual intervention with<br />
methadone treatment in a mosque setting.<br />
The speakers will present four topics that related to the drug problems in Malaysia. The first speaker will talk about harm minimization<br />
and the current drugs and HIV situations in Malaysia. The second speaker will highlight the harm reduction services available emphasizing<br />
pharmacotherapy options available in Malaysia, the challenges and future directions. The third speaker will focus on psychosocial<br />
intervention in particular an innovative psychospiritual intervention called the Spiritual Enhancement of Drug Addiction Rehabilitation<br />
(SEDAR) program in the Malaysian Ar-Rahman mosque. The fourth speaker will discuss Assisted Medication Therapy (AST) from an Islamic<br />
perspective.<br />
Harm minimization approaches in Malaysia are promising. However, the program needs large scale implementation and new strategies<br />
in order to make an impact on HIV/AIDS prevalence.<br />
New and larger platforms and more aggressive promotions are required to implement more harm minimization programs in the<br />
community.<br />
Key words: Addiction, harm minimization, HIV/AIDS, psychospiritual interventions<br />
Bulletin of Clinical Psychopharmacology 2011;21(Suppl. 2):S42<br />
[JS-03]<br />
Hellenic Society for the Advancement of Psychiatry and Related Sciences<br />
Symposium title: Disorders of sleep and wakefulness and their pharmacological management<br />
Depression and the effect of antidepressants on sleep<br />
Thomas Paparrigopoulos<br />
Athens University Medical School, 1st Department of Psychiatry, Athens, Greece<br />
E-mail: tpaparrig@med.uoa.gr<br />
Sleep mechanisms and the pathophysiology of depression are closely interrelated. Monoaminergic and cholinergic neurotransmission<br />
are heavily involved in both. Therefore, it is not surprising that depression is almost invariably associated with sleep abnormalities.<br />
Several hypotheses have been advanced to explain their occurrence. One suggests that an increased pressure of REM sleep might be<br />
responsible. Another proposes that a deficiency in the mechanism responsible for non-REM sleep, as explained by the two-process<br />
model of sleep regulation, may be implicated. Finally, a third hypothesis suggests that an imbalance between the monoaminergic and<br />
cholinergic systems in the central nervous system (CNS) could be responsible for the pathophysiology of depression and the observed<br />
sleep aberrations.<br />
In principle, most antidepressants increase synaptic levels of norepinephrine, serotonin, and dopamine; yet they may also act on<br />
muscarinic and histamine (H1) receptors. These effects purportedly underlie their principal therapeutic mode of action, as well as their<br />
potential mechanism of altering sleep architecture. In this line of thought it has been proposed that central to the therapeutic effect<br />
S42 Bulletin of Clinical Psychopharmacology, Vol: 21, Supplement: 2, 2011 - www.psikofarmakoloji.org